Eli Lilly and Co on Thursday forecast 2008 earnings above Wall Street expectations and said it remained on track to seek U.S. approval this month for prasugrel, a blood clot preventer, which posted mixed results in a recent large clinical trial.
From: news.yahoo.com
Lilly bullish on 2008 earnings
Posted by Ruslan Abuzant at 9:12 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment